In vitro and in vivo evaluation of a folate-targeted copolymeric submicrohydrogel based on N-isopropylacrylamide as 5-fluorouracil delivery system

Polymers

Volumn 3, Issue 3, 2011, Pages 1107-1125

  Blanco, M Dolores ^a   Guerrero, Sandra ^a   Benito, Marta ^a   Fernández Olleros, Ana M ^a   Teijón, César ^b   Olmo, Rosa ^a   Katime, Issa ^c   Teijón, José M ^a  

^a Facultad de Medicina   (Spain)

^b Polymeric Materials Group for the Controlled Release of Bioactive Compounds in Biomedicine   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

5 fluorouracil; Culture cells; Drug delivery; Folate conjugate nanogel; Pharmacokinetic

Indexed keywords

ACRYLIC MONOMERS; AMIDES; COLLAGEN; CONTROLLED DRUG DELIVERY; CYTOLOGY; DRUG DELIVERY; LANTHANUM COMPOUNDS; MUSCULOSKELETAL SYSTEM; PHARMACOKINETICS;

5-FLUOROURACIL; 5-FLUOROURACIL (5-FU); 5-FLUOROURACIL DELIVERY; CULTURE CELLS; MEAN RESIDENCE TIME; N- ISOPROPYLACRYLAMIDE; NANOGELS; PHARMACOKINETIC STUDIES;

TARGETED DRUG DELIVERY;

EID: 83655193370     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym3031107     Document Type: Article

References (47)

1. Ofverholm, A.; Arkblad, E.; Skrtic, S.; Albertsson, P.; Shubbar, E.; Enerback, C. Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene. Clin. Biochem. 2010, 43, 331-334.
2. Moehler, M.; Teufel, A.; Galle, P.R. New chemotherapeutic strategies in colorectal cancer. Recent Results Cancer Res. 2005, 165, 250-259.
3. Goldberg, R.M.; Sargent, D.J.; Morton, R.F.; Fuchs, C.S.; Ramanathan, R.K.; Williamson, S.K.; Findlay, B.P.; Pitot, H.C.; Alberts, S. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: A North American Intergroup Trial. J. Clin. Oncol. 2006, 24, 3347-3353.
4. Pohl, A.; Lurje, G.; Manegold, P.C.; Lenz, H.J. Pharmacogenomics and -genetics in colorectal cancer. Adv. Drug Deliv. Rev. 2009, 61, 375-380.
5. Yarden, Y.; Baselga, J.; Miles, D. Molecular approach to breast cancer treatment. Semin. Oncol. 2004, 31, 6-13.
6. Gunzburg, W.H.; Lohr, M.; Salmons, B. Novel treatments and therapies in development for pancreatic cancer. Expert Opin. Investig. Drugs 2002, 11, 769-786.
7. Nishiyama, M.; Eguchi, H. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy. Adv. Drug Deliv. Rev. 2009, 61, 402-407.
8. Zinutti, C.; Kedzierewicz, F.; Hoffman, M.; Benoit, J.P.; Maincent, P. Influence of the casting solvent on the physico-chemical properties of 5-fluorouracil loaded microspheres. Int. J. Pharm. 1996, 133, 97-105.
9. Yuan, F.; Qin, X.; Zhou, D.; Xiang, Q.Y.; Wang, M.T.; Zhang, Z.R.; Huang, Y. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates. Eur. J. Pharm. Biopharm. 2008, 70, 770-776.
10. Chung, T.W.; Lin, S.Y.; Liu, D.Z.; Tyan, Y.C.; Yang, J.S. Sustained release of 5-FU from poloxamer gels interpenetrated by crosslinking chitosan network. Int. J. Pharm. 2009, 382, 39-44.
11. Blanco, M.D.; Sastre, R.L.; Teijon, C.; Olmo, R.; Teijon, J.M. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D, L-lactide) and poly(lactide-co-glycolide) polymers: Characterization and drug release. J. Microencapsul. 2005, 22, 671-682.
12. Blanco, M.D.; Guerrero, S.; Teijón, C.; Olmo, R.; Pastrana, L.; Katime, I.; Teijón, J.M. Preparation and characterization of nanoparticulate poly(N-isopropylacrylamide) hydrogel for the controlled release of anti-tumour drugs. Polym. Int. 2008, 57, 1215-1225.
13. Sastre, R.L.; Blanco, M.D.; Teijón, C.; Olmo, R.; Teijón, J.M. Preparation and characterization of 5-Fluorouracil-loaded poly(ε-caprolactone) microspheres for drug administration. Drug Dev. Res. 2004, 63, 41-53.
14. Kim, S.; Kim, J.H.; Jeon, O.; Kwon, I.C.; Park, K. Engineered polymers for advanced drug delivery. Eur. J. Pharm. Biopharm. 2009, 71, 420-430.
15. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Nanomedicine: Current status and future prospects. FASEB J. 2005, 19, 311-330.
16. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
17. Jabr-Milane, L.S.; van Vlerken, L.E.; Yadav, S.; Amiji, M.M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev. 2008, 34, 592-602.
18. Vasir, J.K.; Labhasetwar, V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv. Drug Deliv. Rev. 2007, 59, 718-728.
19. Ross, J.F.; Chaudhuri, P.K.; Ratnam, M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994, 73, 2432-2443.
20. Park, E.K.; Lee, S.B.; Lee, Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005, 26, 1053-1061.
21. Aronov, O.; Horowitz, A.T.; Gabizon, A.; Gibson, D. Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies. Bioconjug. Chem. 2003, 14, 563-574.
22. Shmeeda, H.; Mak, L.; Tzemach, D.; Astrahan, P.; Tarshish, M.; Gabizon, A. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Mol. Cancer Ther. 2006, 5, 818-824.
23. Blanco, M.D.; Olmo, R.; Teijón, J.M. Hydrogels. In Encyclopedia of Pharmaceutical Technology; Swarbrick, J., Boylan, J.C., Eds.; Marcel Dekker: New York, NY, USA, 2002; pp. 1-25.
24. Guerrero-Ramírez, L.G.; Nuño-Donlucas, S.M.; Cesteros, L.C.; Katime, I. Smart copolymeric nanohydrogels: Synthesis, characterization and properties. Mat. Chem. Phys. 2008, 112, 1088-1092.
25. Pérez-Álvarez, L.; Sáez-Martínez, V.; Hernáez, E.; Katime, I. Synthesis and characterization of pH-sensitive microgels by derivatization of npa-based reactive copolymers. Mat. Chem. Phys. 2008, 112, 516-524.
26. Pérez-Álvarez, L.; Sáez-Martínez, V.; Hernáez, E.; Katime, I. Specific pH-responsive folate-conjugate microgels designed for antitumor therapy. Macromol. Chem. Phys. 2009, 210, 467-477.
27. Garcia, O.; Trigo, R.M.; Blanco, M.D.; Teijon, J.M. Influence of degree of crosslinking on 5-fluorouracil release from poly(2-hydroxyethyl methacrylate) hydrogels. Biomaterials 1994, 15, 689-694.
28. Davda, J.; Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 2002, 233, 51-59.
29. Panyam, J.; Sahoo, S.K.; Prabha, S.; Bargar, T.; Labhasetwar, V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D, L-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 2003, 262, 1-11.
30. Kelley, K.M.; Rowan, B.G.; Ratnam, M. Modulation of the folate receptor alpha gene by the estrogen receptor: Mechanism and implications in tumor targeting. Cancer Res. 2003, 63, 2820-2828.
31. Sonvico, F.; Mornet, S.; Vasseur, S.; Dubernet, C.; Jaillard, D.; Degrouard, J.; Hoebeke, J.; Duguet, E.; Colombo, P.; Couvreur, P. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: Synthesis, physicochemical characterization, and in vitro experiments. Bioconjug. Chem. 2005, 16, 1181-1188.
32. Lee, E.S.; Na, K.; Bae, Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J. Control. Release 2003, 91, 103-113.
33. MacCarron, P.A.; Woolfson, A.; McCafferty, D.F.; Price, J.H.; Sidhu, H.; Hickey, G.I. Cytotoxicity of 5-Fluorouracil released from a bioadhesive patch into uterine cervical tissue. Int. J. Pharm. 1997, 151, 69-74.
34. Gupte, A.; Ciftci, K. Formulation and characterization of paclitaxel, 5-FU and paclitaxel +5-FU microspheres. Int. J. Pharm. 2004, 276, 93-106.
35. Hernandez-Vargas, H.; Ballestar, E.; Carmona-Saez, P.; von Kobbe, C.; Banon-Rodriguez, I.; Esteller, M.; Moreno-Bueno, G.; Palacios, J. Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int. J. Cancer 2006, 119, 1164-1175.
36. Spector, T.; Cao, S.; Rustum, Y.M.; Harrington, J.A.; Porter, D.J. Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil. Cancer Res. 1995, 55, 1239-1241.
37. Zacharakis, E.; Demetriades, H.; Pramateftakis, M.G.; Lambrou, I.; Zaraboukas, T.; Koliakos, G.; Kanellos, I.; Betsis, D. Effect of IGF-I on healing of colonic anastomoses in rats under 5-FU treatment. J. Surg. Res. 2008, 144, 138-144.
38. Sastre, R.L.; Olmo, R.; Teijon, C.; Muniz, E.; Teijon, J.M.; Blanco, M.D. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D, L-lactide) and poly(D, L-lactide-co-glycolide) polymers. Int. J. Pharm. 2007, 338, 180-190.
39. Ritschel, W.A.; Kearns, G.L. Handbook of Basic Pharmacokinetics-Including Clinical Applications, 6th ed.; American Pharmacists Association (APhA): Washington, DC, USA, 2004.
40. Ackland, S.P.; Garg, M.B.; Dunstan, R.H. Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography. Anal. Biochem. 1997, 246, 79-85.
41. Diasio, R.B.; Harris, B.E. Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet. 1989, 16, 215-237.
42. Shin, S.C.; Choi, J.S.; Li, X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int. J. Pharm. 2006, 313, 144-149.
43. Shah, V.P.; Midha, K.K.; Dighe, S.; McGilveray, I.J.; Skelly, J.P.; Yacobi, A.; Layloff, T.; Viswanathan, C.T.; Cook, C.E.; McDowall, R.D.; et al. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 1992, 81, 309-312.
44. Han, X.; Liu, J.; Liu, M.; Xie, C.; Zhan, C.; Gu, B.; Liu, Y.; Feng, L.; Lu, W. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro. Int. J. Pharm. 2009, 372, 125-131.
45. Buckpitt, A.R.; Boyd, M.R. A sensitive method for determination of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in human plasma by high-pressure liquid chromatography. Anal. Biochem. 1980, 106, 432-437.
46. Berrozpe, J.D. Biofarmacia y Farmacocinética. In Farmacocinética; Berrozpe, J.D., Lanao, J.M., Delfina, J.M.P., Eds.; Síntesis: Madrid, Spain, 1997; Volume I.
47. Humason, G.L. Animal Tissue Techniques, 4th ed.; Freeman W. H.: New York, NY, USA, 1979.